Fidelity Select Pharmaceuticals Portfolio (FPHAX)
31.44
+0.15
(+0.48%)
USD |
Jan 16 2026
FPHAX Asset Allocations & Exposures
Asset Allocation
As of November 30, 2025.
| Type | % Net |
|---|---|
| Cash | 1.10% |
| Stock | 95.29% |
| Bond | 0.87% |
| Convertible | 0.00% |
| Preferred | 0.56% |
| Other | 2.18% |
Market Capitalization
As of November 30, 2025
| Large | 74.37% |
| Mid | 5.08% |
| Small | 20.56% |
Region Exposure
| Americas | 66.04% |
|---|---|
|
North America
|
66.04% |
| Canada | 0.92% |
| United States | 65.12% |
|
Latin America
|
0.00% |
As of November 30, 2025. Region breakdown data is
calculated by using the long position holdings of the portfolio.
| Greater Europe | 30.03% |
|---|---|
| United Kingdom | 16.08% |
|
Europe Developed
|
13.94% |
| Belgium | 6.50% |
| Denmark | 2.26% |
| Germany | 1.02% |
| Ireland | 1.41% |
| Netherlands | 1.56% |
| Switzerland | 1.19% |
|
Europe Emerging
|
0.00% |
|
Africa And Middle East
|
0.00% |
| Greater Asia | 0.00% |
|---|---|
| Japan | 0.00% |
|
Australasia
|
0.00% |
|
Asia Developed
|
0.00% |
|
Asia Emerging
|
0.00% |
| Unidentified Region | 3.94% |
|---|
Stock Sector Exposure
| Cyclical |
|
0.00% |
| Materials |
|
0.00% |
| Consumer Discretionary |
|
0.00% |
| Financials |
|
0.00% |
| Real Estate |
|
0.00% |
| Sensitive |
|
0.00% |
| Communication Services |
|
0.00% |
| Energy |
|
0.00% |
| Industrials |
|
0.00% |
| Information Technology |
|
0.00% |
| Defensive |
|
97.38% |
| Consumer Staples |
|
0.00% |
| Health Care |
|
97.38% |
| Utilities |
|
0.00% |
| Not Classified |
|
2.62% |
| Non Classified Equity |
|
0.69% |
| Not Classified - Non Equity |
|
1.93% |
As of November 30, 2025
Stock Style Exposure
| Large Cap Value | -- |
| Large Cap Core | -- |
| Large Cap Growth | -- |
| Mid Cap Value | -- |
| Mid Cap Core | -- |
| Mid Cap Growth | -- |
| Small Cap Value | -- |
| Small Cap Core | -- |
| Small Cap Growth | -- |